Literature DB >> 11108278

High levels of glucose stimulate angiotensinogen gene expression via the P38 mitogen-activated protein kinase pathway in rat kidney proximal tubular cells.

S L Zhang1, S S Tang, X Chen, J G Filep, J R Ingelfinger, J S Chan.   

Abstract

The present studies investigated whether the effect of high levels of glucose on angiotensinogen (ANG) secretion and gene expression in kidney proximal tubular cells is mediated at least in part via the activation of p38 mitogen-activated protein kinase (p38 MAPK). Rat immortalized renal proximal tubular cells (IRPTCs) were cultured in monolayer. The levels of immunoreactive rat ANG (IR-rANG) secreted into the medium and the levels of cellular ANG messenger RNA were determined by a specific RIA for rat ANG and a RT-PCR assay, respectively. Phosphorylation of cellular p38 MAPK was determined by Western blot analysis using the Phospho Plus p38 MAPK antibody kit. High levels of glucose (i.e. 25 mM) and phorbol 12-myristate 13-acetate (PMA; 10(-7) M) increased the secretion of IR-rANG and cellular ANG messenger RNA as well as phosphorylation of p38 MAPK in IRPTCs. This stimulatory effect of high levels of glucose and PMA was blocked by SB 203580 (a specific inhibitor of p38 MAPK), but not by SB 202474 (a negative control of SB 203580). High levels of D-sorbitol or 2-deoxy-D-glucose (i.e. > or = 35 mM) also stimulated the phosphorylation of p38 MAPK, but did not stimulate ANG secretion or gene expression. GF 109203X (an inhibitor of protein kinase C) blocked the stimulatory effect of high levels of glucose and PMA on ANG gene expression, whereas it did not block the effect of high levels of glucose, sorbitol, or 2-deoxy-D-glucose on p38 MAPK phosphorylation in IRPTCs. These studies demonstrate that the stimulatory effect of a high level of glucose (25 mM) on ANG gene expression in IRPTCS may be mediated at least in part via activation of p38 MAPK signal transduction pathway and is protein kinase C independent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108278     DOI: 10.1210/endo.141.12.7844

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

1.  Novel mechanism of blood pressure regulation by forkhead box class O1-mediated transcriptional control of hepatic angiotensinogen.

Authors:  Yajuan Qi; Kebin Zhang; Yuxin Wu; Zihui Xu; Qian Chen Yong; Rajesh Kumar; Kenneth M Baker; Qinglei Zhu; Shouwen Chen; Shaodong Guo
Journal:  Hypertension       Date:  2014-07-28       Impact factor: 10.190

2.  High glucose up-regulates angiotensin II subtype 2 receptors via interferon regulatory factor-1 in proximal tubule epithelial cells.

Authors:  Quaisar Ali; Rifat Sabuhi; Tahir Hussain
Journal:  Mol Cell Biochem       Date:  2010-07-02       Impact factor: 3.396

3.  Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases.

Authors:  Hiroyuki Kobori; Yuri Ozawa; Yuki Suzaki; Minolfa C Prieto-Carrasquero; Akira Nishiyama; Tatsuya Shoji; Eric P Cohen; L Gabriel Navar
Journal:  Am J Hypertens       Date:  2006-05       Impact factor: 2.689

4.  Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients.

Authors:  Hiroyuki Kobori; Akemi Katsurada; Yuri Ozawa; Ryousuke Satou; Kayoko Miyata; Naoki Hase; Yuki Suzaki; Tatsuya Shoji
Journal:  Biochem Biophys Res Commun       Date:  2007-04-26       Impact factor: 3.575

5.  Mycophenolic acid inhibits albumin-induced MCP-1 expression in renal tubular epithelial cells through the p38 MAPK pathway.

Authors:  Hua Shui; Ping Gao; Xiaoyun Si; Guohua Ding
Journal:  Mol Biol Rep       Date:  2009-07-04       Impact factor: 2.316

6.  Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice.

Authors:  A K H Lim; D J Nikolic-Paterson; F Y Ma; E Ozols; M C Thomas; R A Flavell; R J Davis; G H Tesch
Journal:  Diabetologia       Date:  2008-12-09       Impact factor: 10.122

7.  Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetes.

Authors:  Masumi Kamiyama; Andrea Zsombok; Hiroyuki Kobori
Journal:  J Pharmacol Sci       Date:  2012-07-31       Impact factor: 3.337

8.  Heterogeneous nuclear ribonucleoprotein F suppresses angiotensinogen gene expression and attenuates hypertension and kidney injury in diabetic mice.

Authors:  Chao-Sheng Lo; Shiao-Ying Chang; Isabelle Chenier; Janos G Filep; Julie R Ingelfinger; Shao Ling Zhang; John S D Chan
Journal:  Diabetes       Date:  2012-06-04       Impact factor: 9.461

9.  Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy.

Authors:  Susumu Ogawa; Hiroyuki Kobori; Naro Ohashi; Maki Urushihara; Akira Nishiyama; Takefumi Mori; Tsuneo Ishizuka; Kazuhiro Nako; Sadayoshi Ito
Journal:  Biomark Insights       Date:  2009-06-23

Review 10.  Inflammation in diabetic nephropathy.

Authors:  Andy K H Lim; Gregory H Tesch
Journal:  Mediators Inflamm       Date:  2012-08-21       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.